Joinder and Counterpart Signature Page to Registration Rights Agreement by Capstone Therapeutics Corp. and Lipimetix Development, Inc.
This document is a joinder to a Registration Rights Agreement originally dated August 25, 2016, involving Lipimetix Development, Inc., its common holders, and investors. By signing, Capstone Therapeutics Corp. agrees to become an "Investor" under the agreement, accepting all related rights and obligations as if it were an original party. The agreement concerns the rights of investors to register their shares for public sale, and this joinder makes Capstone subject to those terms as of August 11, 2017.
EXHIBIT 10.3
JOINDER AND COUNTERPART SIGNATURE PAGE OF
REGISTRATION RIGHTS AGREEMENT OF
LIPIMETIX DEVELOPMENT, INC.
As of August 11, 2017, the undersigned has executed this counterpart signature to the Registration Rights Agreement entered into as of August 25, 2016, by and among the Company, the Common Holders and the Investors (as such terms are defined therein), and does hereby agree to be bound by all of the obligations as an “Investor” thereunder and the terms thereof as though originally an Investor thereto.
CAPSTONE THERAPEUTICS CORP.,
a Delaware corporation
By: /s/ Leslie M. Taeger
Name: Leslie M. Taeger
Title: CFO
